Pilomyxoid astrocytomas is an uncommon aggressive piloid neoplasm, closely related to pilocytic astrocytomas and typically presents in the very young but can occur in older children and rarely in adults. A 12-years-old male presented with focal seizures, headache and vomiting of 10 days duration. Computed tomogram showed a hypo-to hyperdense and peripherally enhancing, solid-cystic lesion in the left temporal lobe. Histopathological examination revealed a characteristic tumor composed of bipolar cells arranged in dyscohesive sheets, angiocentric pattern in a loose myxoid background, with brisk mitotic activity and foci of necrosis. No Rosenthal fibers or eosinophilic granular bodies were seen. The tumor cells showed strong GFAP and scattered p53 positivity, but were negative for EMA. Ki-67 positivity ranged from 30 to 40%, highest reported till date. The patient was treated with radiotherapy and concurrent temozolamide and the tumor recurred after two years.
Introduction
Pilomyxoid astrocytoma (PMA) is an uncommon progressive piloid neoplasm, closely related to pilocytic astrocytoma (PA). [1] Originally described by Janisch et al., [2] in 1985 as 'diencephalic pilocytic astrocytoma with clinical onset in infancy', the term pilomyxoid astrocytoma was introduced in 1999 by Tihan et al. [3] It has been recognized as a separate entity in WHO classification of Central Nervous System Tumors in 2007 because of its distinct histological features and labeled grade II tumor owing to its aggressiveness. [1] This tumor typically presents in young children (median: 10 months), but can also occur in older children and is rare in adults. [1] Case Report A 12-years-old male presented with focal seizures, headache and vomiting of 10 days duration. On clinical examination there were no neurological deficits or papilledema. Computed tomogram (CT) scan of the brain showed a solid-cystic lesion in the left temporal lobe, which was hypo-to hyperdense with peripheral contrast enhancement [ Figure 1 ]. Gross total resection of the tumor was done and sent for histopathological examination. Immediate post-operative period and further recovery was uneventful. {Figure 1} Microscopic examination showed a cellular tumor, composed of monomorphous, bipolar cells arranged in dyscohesive sheeting pattern [ Figure 2 
Discussion
The review of literature shows less than 100 cases of pilomyxoid astrocytoma being reported till date (PubMed search as on 12 th June 2013). The mean age at diagnosis for patients with PMA has been documented to be 18 months. [4] Apart from the commonest site of hypothalamic/chiasmatic region, this entity has also been described in thalamus, cerebellum, brain stem, temporal lobe and spinal cord. [1] Pilomyxoid astrocytoma most commonly presents with symptoms of raised intracranial pressure or parenchymal compression. [4] The presenting symptoms of hypothalamic juvenile PMA are vomiting, feeding difficulties, developmental delay and failure to thrive. [2] On magnetic resonance imaging, these tumors are well circumscribed without evidence of peritumoral edema or parenchymal infiltration. [5] The majority (84.6%) are solid, with the remainder showing a minimal cystic component. Radiographic evidence of central necrosis is rare and PMA tends to enhance homogeneously on contrast. [4] , [5] Presentation at younger age, more frequent occurrence in the suprasellar area, mainly solid mass containing non-enhancing portion and more frequent leptomeningeal dissemination, are helpful differential features of PMAs as compared to PAs. [6] Angiocentric immunopositivity for GFAP, S-100 and Vimentin. [1] Though the angiocentric/pseudorosette pattern may mimic ependymoma, but absence of perinuclear dot expression of EMA in the present case of PMA differentiated it from ependymoma. Poor prognostic indicators in gliomas, that is necrosis, mitotic figures and vascular proliferation, are not uncommon in PMAs. [7] The occurrence in the setting of neurofibromatosis type 1 (NF-1) and KIAA1549:BRAF fusions have been reported in PMA. [8] , [9] Patients with PMA experience shorter progression free survival and higher local recurrence than those with juvenile PA. [4] Intra-cerebral metastasis of an intramedullary PMA, [10] leptomeningeal dissemination [11] and rapid progression to glioblastoma [12] It is important to separately recognize PMA from PA due to its propensity to involve younger age group, aggressiveness, higher local recurrence, metastasis, CSF spread and progression. Increased mitotic activity, proliferation index and necrosis or endothelial proliferation necessitates adjuvant therapy. Further follow-up and larger studies are needed to more accurately determine the prognosis of these tumors.
